FDA Approves U.S. Babies and Young Children to Get Omicron COVID Booster Shots
In early December 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer/BioNTech and Moderna/NIAID mRNA COVID-19 shots to include administration of the Omicron COVID booster shots to children as young as six months old. The action allows everyone over the age of six months to get the […]
Blaming Unvaccinated Americans. Here We Go Again.
Opinion | Fueled by the phrase, “pandemic of the unvaccinated,” last year many corporate media outlets began running a series of articles attacking people who chose to exercise their medical informed consent rights and not get vaccinated for COVID-19. The hit pieces laid the blame for the continuing COVID pandemic squarely on the shoulders of unvaccinated […]
Oxford Study Finds Increased COVID Infection Rate Among the COVID Vaccinated
Researchers from Oxford University in the United Kingdom published a study in The Lancet finding that those who received two doses of COVID-19 shot were 44 percent more likely to be infected with the SARS-CoV-2 virus than those who were unvaccinated.1 2 The study, published on June 30 2022, collected data from Dec. 8, 2020 […]
New COVID Shots Same As Old Ones
Two studies performed recently at Columbia University and Harvard University have found that the new COVID-19 bivalent (two-in-one) booster shots developed by Pfizer/BioNTech and Moderna/NIAID do not provide better protection against the BA.4 and BA.5 Omicron subvariant viruses than the original monovalent formulations of the shots.1 2 3 In the Columbia study, 19 people were […]
FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?
With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]
